Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

31.05.2021

2 Am J Cardiol
1 Am J Med
3 Ann Thorac Surg
2 Arterioscler Thromb Vasc Biol
2 Chest
1 Circ Genom Precis Med
4 Circulation
6 Clin Cardiol
23 Eur Heart J
112 Int J Cardiol
4 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
2 J Mol Cell Cardiol
3 J Thorac Cardiovasc Surg
2 N Engl J Med



    Am J Cardiol

  1. KRITTANAWONG C, Yue B, Mahtta D, Kumar A, et al
    Hospital Readmission in Patients With Spontaneous Coronary Artery Dissection.
    Am J Cardiol. 2021 May 21. pii: S0002-9149(21)00321.
    >> Share

  2. CHEZAR-AZERRAD C, Musallam A, Shea C, Zhang C, et al
    One-Year Outcomes After Treatment of Ostial In-Stent Restenosis in Left Circumflex Versus Left Anterior Descending or Right Coronary Artery.
    Am J Cardiol. 2021 May 21. pii: S0002-9149(21)00315.
    >> Share


    Am J Med

  3. PAGIDIPATI NJ, Deedwania DP
    A comprehensive cardiovascular-renal-metabolic risk reduction approach to patients with Type 2 Diabetes Mellitus.
    Am J Med. 2021 May 21. pii: S0002-9343(21)00317.
    >> Share


    Ann Thorac Surg

  4. ABDULKARIM M, Weld J, Cohen W, Combs P, et al
    Congenitally Abnormal Aortic Valve causing Coronary Obstruction and Cardiac Arrest in Infancy.
    Ann Thorac Surg. 2020 Oct 15. pii: S0003-4975(20)31686.
    >> Share

  5. ANDERSON M, Smith D, Kane P, Lee R, et al
    Impella 5.5 Direct Aortic Implant and Explant Techniques.
    Ann Thorac Surg. 2021;111:e373-e375.
    >> Share

  6. TEMAN NR, Hawkins RB, Charles EJ, Mehaffey JH, et al
    Minimally Invasive vs Open Coronary Surgery: A Multi-Institutional Analysis of Cost and Outcomes.
    Ann Thorac Surg. 2021;111:1478-1484.
    >> Share


    Arterioscler Thromb Vasc Biol


  7. Correction to: Naive CD8(+) T Cells Expressing CD95 Increase Human Cardiovascular Disease Severity.
    Arterioscler Thromb Vasc Biol. 2021;41:e383.
    >> Share

  8. CHATZOPOULOU E, Range H, Deraz O, Boutouyrie P, et al
    Poor Masticatory Capacity and Blood Biomarkers of Elevated Cardiovascular Disease Risk in the Community: The Paris Prospective Study III.
    Arterioscler Thromb Vasc Biol. 2021 May 27:ATVBAHA121316085.
    >> Share


    Chest

  9. WEI Y, Lv J, Guo Y, Bian Z, et al
    Age-specific associations between habitual snoring and cardiovascular diseases in China: a 10-year cohort study.
    Chest. 2021 May 21. pii: S0012-3692(21)00905-3. doi: 10.1016/j.chest.2021.
    >> Share

  10. TAN LD
    Further Insight Into the Intimate Relationship Between Asthma and Cardiovascular Disease.
    Chest. 2021;159:1311-1312.
    >> Share


    Circ Genom Precis Med

  11. CHRISTIANSEN MK, Winther S, Nissen L, Vilhjalmsson BJ, et al
    Polygenic Risk Score-enhanced Risk Stratification of Coronary Artery Disease in Patients with Stable Chest Pain.
    Circ Genom Precis Med. 2021 May 25. doi: 10.1161/CIRCGEN.120.003298.
    >> Share


    Circulation

  12. ALTHOUSE AD, Below JE, Claggett BL, Cox NJ, et al
    Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.
    Circulation. 2021 May 25:CIRCULATIONAHA121055393.
    >> Share

  13. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    >> Share

  14. CHANG AY, Barry M, Harrington RA
    The Need to Expand the Framework of Environmental Determinants of Cardiovascular Health From Climate Change to Planetary Health: Trial by Wildfire.
    Circulation. 2021;143:2029-2031.
    >> Share

  15. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    >> Share


    Clin Cardiol

  16. KAIHARA T, Higuma T, Izumo M, Kotoku N, et al
    Influence of coronary artery disease and percutaneous coronary intervention on mid-term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23655.
    >> Share

  17. LAM ASM, Yan BPY, Lee VWY
    Efficacy and safety comparing prasugrel/ticagrelor and clopidogrel in Hong Kong post-acute coronary syndrome patients-A 10-year cohort study.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23653.
    >> Share

  18. WANG SJ, Zhao HY, Fan XT
    Reply to the Letter to the Editor Entitled "Optimal risk stratification and therapeutic strategy for acute myocardial infarction".
    Clin Cardiol. 2021 May 22. doi: 10.1002/clc.23646.
    >> Share

  19. EGGERS KM, Baron T, Hjort M, Nordenskjold AM, et al
    Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries.
    Clin Cardiol. 2021 May 25. doi: 10.1002/clc.23651.
    >> Share

  20. MENG Z, Yang J, Wu J, Zheng X, et al
    Association between the platelet-lymphocyte ratio and short-term mortality in patients with non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23648.
    >> Share

  21. TOMER O, Leibowitz D, Einhorn-Cohen M, Shlomo N, et al
    The impact of short hospital stay on prognosis after acute myocardial infarction: An analysis from the ACSIS database.
    Clin Cardiol. 2021 May 26. doi: 10.1002/clc.23652.
    >> Share


    Eur Heart J

  22. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    >> Share

  23. DAVIES A, Fox K, Galassi AR, Banai S, et al
    Management of refractory angina: an update.
    Eur Heart J. 2021;42:269-283.
    >> Share

  24. IBANEZ B, Roque D, Price S
    The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care.
    Eur Heart J. 2021;42:884-895.
    >> Share

  25. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    >> Share

  26. RAY KK
    Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care.
    Eur Heart J. 2021;42:253-256.
    >> Share

  27. ZHANG H, Xiao Z, Yang P, Hu J, et al
    Ruptured coronary artery aneurysm mimicking as a giant mediastinal mass.
    Eur Heart J. 2021;42:1183.
    >> Share

  28. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    >> Share

  29. SICARI R
    The curious incident of CFVR in clinical practice.
    Eur Heart J. 2021;42:240-242.
    >> Share

  30. WANG X, Yan C
    Progression of artery aneurysm after transcatheter closure of coronary artery fistula.
    Eur Heart J. 2021;42:918.
    >> Share

  31. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
    Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
    Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
    >> Share

  32. ARSENOS P, Antoniou CK, Gatzoulis KA
    Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
    Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.
    >> Share

  33. JOBS A, Collet JP, Thiele H
    Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?
    Eur Heart J. 2021;42:353-354.
    >> Share

  34. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    >> Share

  35. PLAT J, Strandberg TE, Gylling H
    Intestinal cholesterol and phytosterol absorption and the risk of coronary artery disease.
    Eur Heart J. 2021;42:281-282.
    >> Share

  36. HELGADOTTIR A, Thorleifsson G, Stefansson K
    Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers.
    Eur Heart J. 2021;42:283-284.
    >> Share

  37. ABDELWAHED YS, Wurster TH, Landmesser U, Leistner DM, et al
    Culprit mistaken: development of a traumatic coronary aneurysm after mismatched culprit lesion-PCI for plaque rupture.
    Eur Heart J. 2021;42:287.
    >> Share

  38. ERDMANN J, van der Laan SW
    Unfolding and disentangling coronary vascular disease through genome-wide association studies.
    Eur Heart J. 2021;42:934-937.
    >> Share

  39. MARENZI G, Cosentino N, Cardinale D
    Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
    Eur Heart J. 2021;42:1035-1037.
    >> Share


  40. Corrigendum to: Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials.
    Eur Heart J. 2021 May 23. pii: 6282430. doi: 10.1093.
    >> Share

  41. SCHRODER J, Michelsen MM, Mygind ND, Suhrs HE, et al
    Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Eur Heart J. 2021;42:228-239.
    >> Share

  42. VARBO A, Nordestgaard BG
    Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
    Eur Heart J. 2021 May 23. pii: 6282433. doi: 10.1093.
    >> Share

  43. VAN DER STOUWE JG, Boeddinghaus J, Mueller C
    Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
    Eur Heart J. 2021 May 23. pii: 6282428. doi: 10.1093.
    >> Share

  44. HOLT A, Blanche P, McGettigan P, Lamberts M, et al
    Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis.
    Eur Heart J. 2021 May 23. pii: 6282429. doi: 10.1093.
    >> Share


    Int J Cardiol

  45. LEONE AM, Arioti M, Cialdella P, Vergallo R, et al
    Prognostic impact of FFR/contrast FFR discordance.
    Int J Cardiol. 2021;327:40-44.
    >> Share

  46. LAWLESS M, Harrison AS, Doherty P
    Multiple interventions following an acute coronary syndrome event increase uptake into cardiac rehabilitation.
    Int J Cardiol. 2021;326:1-5.
    >> Share

  47. ZHAI Y, Yang J, Zhang J, Yang J, et al
    miRNA-3614 derived from epicardial adipose tissue: A novel target for ischemic heart diseases.
    Int J Cardiol. 2021;326:157.
    >> Share

  48. GRESELE P, Guglielmini G, Del Pinto M, Calabro P, et al
    Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry.
    Int J Cardiol. 2021;327:176-182.
    >> Share

  49. SHIMA Y, Miura K, Shimada T, Ohya M, et al
    Impact of ischemic risk factors on long-term outcomes in patients with and without high bleeding risk.
    Int J Cardiol. 2021;326:12-18.
    >> Share

  50. CAI Q, Gao ML, Huang LS, Pan LH, et al
    lncRNA H19/miRNA-1: Another potential mechanism for treating myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2021;322:57.
    >> Share

  51. BRUNO VD, Zakkar M
    Instantaneous wave- free ratio for decision making in cardiac surgery, an important step in the right direction.
    Int J Cardiol. 2021;326:71-72.
    >> Share

  52. LOPEZ-DE-SA E
    Acute coronary occlusion in non-STEMI: If you change the way you look at things, the things you look at change.
    Int J Cardiol. 2021;322:49-50.
    >> Share

  53. RAVAL AN, Johnston PV, Duckers HJ, Cook TD, et al
    Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
    Int J Cardiol. 2020 Oct 19. pii: S0167-5273(20)33996.
    >> Share

  54. LIU H, Xie G, Huang W, Liu J, et al
    Rationale and design of a multicenter, randomized, patients-blinded two-stage clinical trial on effects of endothelial function test in patients with non-obstructive coronary artery disease (ENDOFIND).
    Int J Cardiol. 2021;325:16-22.
    >> Share

  55. LAUKKANEN JA, Kunutsor SK
    Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials.
    Int J Cardiol. 2021;324:13-21.
    >> Share

  56. WU X, Ma JN, Shen LJ, Hu SY, et al
    Reply to "The differential diagnosis of STEMI should also be taken into account".
    Int J Cardiol. 2021;322:55.
    >> Share

  57. OZGEYIK M, Okay Ozgeyik M, Yildirim OT
    Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population.
    Int J Cardiol. 2021;322:56.
    >> Share

  58. SONG X
    The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation.
    Int J Cardiol. 2021;323:22.
    >> Share

  59. ZHOU J, Chin CT, Huang X, Guo N, et al
    Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia study.
    Int J Cardiol. 2021;327:19-24.
    >> Share

  60. TAMARAPPOO B, Samuel TJ, Elboudwarej O, Thomson LEJ, et al
    Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
    Int J Cardiol. 2021;327:25-30.
    >> Share

  61. JEFFRIES A, Costello B, Corkill W, Varghese S, et al
    Prognostic value of coronary artery calcium scoring and computed tomography coronary angiography in remote Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2021;328:241-246.
    >> Share

  62. COHEN ARAZI H, Chirino D, Costabel JP, Pulmari CA, et al
    Leuko-platelet index predicts thrombotic events in patients with acute coronary syndrome.
    Int J Cardiol. 2021;328:29-34.
    >> Share

  63. LEDDA RE, Milanese G, Sverzellati N
    Might EAT composition help to predict coronary artery disease severity?
    Int J Cardiol. 2021;327:39.
    >> Share

  64. MONTALTO C, Crimi G, Morici N, Piatti L, et al
    Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.
    Int J Cardiol. 2021;328:22-28.
    >> Share

  65. EARLE NJ, Poppe KK, Rolleston A, Devlin G, et al
    Outcomes for working age patients after first-time acute coronary syndrome - ANZACS-QI 35.
    Int J Cardiol. 2021;328:55-58.
    >> Share

  66. NICOLAS J, Claessen BE, Cao D, Chiarito M, et al
    A sex paradox in clinical outcomes following complex percutaneous coronary intervention.
    Int J Cardiol. 2021;329:67-73.
    >> Share

  67. PAPP S, Barczi G, Karady J, Kolossvary M, et al
    Coronary plaque burden of the left anterior descending artery in patients with or without myocardial bridge: A case-control study based on coronary CT-angiography.
    Int J Cardiol. 2021;327:231-235.
    >> Share

  68. PAVASINI R, Cardelli LS, Piredda A, Tonet E, et al
    Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes.
    Int J Cardiol. 2021;327:31-35.
    >> Share

  69. YING S, Li X
    Renal insufficiency and outcomes in patients with acute coronary syndrome.
    Int J Cardiol. 2021;327:36.
    >> Share

  70. HUANG W, Wu X, Xue Y, Zhou Y, et al
    Reply to the Letter to the Editor: "The role of miRNA in regulating epicardial adipose tissue (EAT) inflammation".
    Int J Cardiol. 2021;327:37.
    >> Share

  71. JINNOUCHI H, Sato Y, Cheng Q, Janifer C, et al
    Thromboresistance and endothelial healing in polymer-coated versus polymer-free drug-eluting stents: Implications for short-term dual anti-platelet therapy.
    Int J Cardiol. 2021;327:52-57.
    >> Share

  72. TAVENIER AH, Hermanides RS, Fabris E, Angiolillo DJ, et al
    Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI.
    Int J Cardiol. 2021;328:40-45.
    >> Share

  73. LI L, Guan C, Meng S, Bai Y, et al
    Short- and long-term functional results following drug-coated balloons versus drug- eluting stents in small coronary vessels: The RESTORE quantitative flow ratio study.
    Int J Cardiol. 2021;327:45-51.
    >> Share

  74. RIEHLE L, Frohlich GM
    Reply to "Comment on: Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population".
    Int J Cardiol. 2021;327:38.
    >> Share

  75. CASE BC, Yerasi C, Forrestal BJ, Shlofmitz E, et al
    Intravascular ultrasound guidance in the evaluation and treatment of left main coronary artery disease.
    Int J Cardiol. 2021;325:168-175.
    >> Share

  76. SABBAH M, Engstrom T, Nepper-Christensen L, Lonborg J, et al
    Does infarct localization and collateral supply confound the association between antiplatelet treatment and infarct size in STEMI?
    Int J Cardiol. 2021;326:42.
    >> Share

  77. KEECH A, Way K, Holgate K, Fildes J, et al
    HIIT for post-COVID patients within cardiac rehabilitation: Response to letter to the editor.
    Int J Cardiol. 2021;322:291-292.
    >> Share

  78. POLYAKOVA EA, Zaraiskii MI, Mikhaylov EN, Baranova EI, et al
    Association of myocardial and serum miRNA expression patterns with the presence and extent of coronary artery disease: A cross-sectional study.
    Int J Cardiol. 2021;322:9-15.
    >> Share

  79. MANGIACAPRA F, Bressi E, Viscusi MM, Creta A, et al
    Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study.
    Int J Cardiol. 2021;322:16-22.
    >> Share

  80. MADIAS JE
    Electrocardiogram features and course in patients with takotsubo syndrome.
    Int J Cardiol. 2021;324:22.
    >> Share

  81. DAI Y, Huang J, Chen Y, Chang S, et al
    Circulating CD34+VEGFR-2+ endothelial progenitor cells correlate with revascularization-mediated long-term improvement of cardiac function in patients with coronary chronic total occlusions.
    Int J Cardiol. 2021;322:1-8.
    >> Share

  82. PENG Y, Du X, Li X, Ji J, et al
    Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China.
    Int J Cardiol. 2021;323:7-12.
    >> Share

  83. WU L, Yu J, Wang Q, Lu Y, et al
    Effects of nalbuphine on the cardioprotective effect of morphine in rats.
    Int J Cardiol. 2021;322:207-210.
    >> Share

  84. KATAJA A, Tarvasmaki T, Lassus J, Sionis A, et al
    Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock - Insights from the CardShock study.
    Int J Cardiol. 2021;322:191-196.
    >> Share

  85. KATAOKA Y, Doi T
    Coronary artery ectasia: Importance of its risk stratification and management.
    Int J Cardiol. 2021;322:43-44.
    >> Share

  86. LUSINI M, Nenna A, Chello M
    Endocannabinoid system: A new player in the percutaneous and surgical treatment of coronary artery disease?
    Int J Cardiol. 2021;322:211-212.
    >> Share

  87. PASTORI D, Carnevale R, Stanzione R, Nocella C, et al
    T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
    Int J Cardiol. 2020 Aug 27. pii: S0167-5273(20)33704.
    >> Share

  88. GUI D, Huang W
    Coronary artery disease is accompanied by increased epicardial fat volume.
    Int J Cardiol. 2021;323:21.
    >> Share

  89. LAKSHMANAN S, Budoff MJ
    Where ISCHEMIA fails, coronary CTA shines.
    Int J Cardiol. 2021;322:40-42.
    >> Share

  90. CHOI KH, Lee SH, Lee JM, Hwang D, et al
    Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease.
    Int J Cardiol. 2021;325:23-29.
    >> Share

  91. JOLOBE OMP
    The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.
    >> Share

  92. JOLOBE OMP
    The differential diagnosis of STEMI should also be taken into account.
    Int J Cardiol. 2021;323:19.
    >> Share

  93. SARAIVA FA, Cerqueira RJ, Savarese G, Leite-Moreira AF, et al
    The tight tie of MAG versus SAG in CABG.
    Int J Cardiol. 2021;323:26.
    >> Share

  94. FRACASSI F, Niccoli G, Cosentino N, Eligini S, et al
    Human monocyte-derived macrophages: Pathogenetic role in plaque rupture associated to systemic inflammation.
    Int J Cardiol. 2021;325:1-8.
    >> Share

  95. VALLABHAJOSYULA S
    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
    >> Share

  96. KATAOKA T, Harada K, Tanaka A, Onishi T, et al
    Relationship between epicardial adipose tissue volume and coronary artery spasm.
    Int J Cardiol. 2021;324:8-12.
    >> Share

  97. LI D, Xiong G, Zeng H, Zhou Q, et al
    Machine learning-aided risk stratification system for the prediction of coronary artery disease.
    Int J Cardiol. 2021;326:30-34.
    >> Share

  98. SURUGA K, Miyoshi T, Kotani K, Ichikawa K, et al
    Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated with high-risk coronary plaque characteristics determined by CT angiography.
    Int J Cardiol. 2021;324:193-198.
    >> Share

  99. VENETSANOS D, Omerovic E, Sarno G, Pagonis C, et al
    Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.
    Int J Cardiol. 2021;325:30-36.
    >> Share

  100. IANNACCONE M, Albani S, Giannini F, Colangelo S, et al
    Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies.
    Int J Cardiol. 2021;324:44-51.
    >> Share

  101. WADA T, Shiono Y, Kubo T, Honda K, et al
    Impact of instantaneous wave-free ratio on graft failure after coronary artery bypass graft surgery.
    Int J Cardiol. 2021;324:23-29.
    >> Share

  102. HUANG W, Wu X, Xue Y, Zhou Y, et al
    MicroRNA-3614 regulates inflammatory response via targeting TRAF6-mediated MAPKs and NF-kappaB signaling in the epicardial adipose tissue with coronary artery disease.
    Int J Cardiol. 2021;324:152-164.
    >> Share

  103. SELVANAYAGAM JB, Ananthakrishna R, Shirodaria C, Channon K, et al
    Timing of cardiovascular magnetic resonance in clinical trials evaluating cardioprotective therapies to reduce infarct size.
    Int J Cardiol. 2021;323:272-274.
    >> Share

  104. ALMENDRO-DELIA M, Seoane Garcia T, Villar Calle P, Garcia Gonzalez N, et al
    Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes.
    Int J Cardiol. 2021;324:1-7.
    >> Share

  105. IBRAHIM IM, Farag EM, Tabl MAE, Abdelaziz M, et al
    Relationship between sclerostin and coronary tortuosity in postmenopausal females with non-obstructive coronary artery disease.
    Int J Cardiol. 2021;322:29-33.
    >> Share

  106. YAMADA H
    Epicardial adipose tissue volume is not a simple marker of coronary artery disease.
    Int J Cardiol. 2021;322:45.
    >> Share

  107. SUGISAWA J, Matsumoto Y, Takeuchi M, Suda A, et al
    Beneficial effects of exercise training on physical performance in patients with vasospastic angina.
    Int J Cardiol. 2021;328:14-21.
    >> Share

  108. VERWEIJ L, Jorstad HT, Minneboo M, Ter Riet G, et al
    The influence of partners on successful lifestyle modification in patients with coronary artery disease.
    Int J Cardiol. 2021;332:195-201.
    >> Share

  109. SUPPOGU N, Wei J, Quesada O, Shufelt C, et al
    Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
    Int J Cardiol. 2021;333:35-39.
    >> Share

  110. STEINER J, Kerschl M, Erbay A, Abdelwahed YS, et al
    Impact of renal function on outcomes of patients with cardiac troponin elevation and non-obstructive coronary arteries.
    Int J Cardiol. 2021;333:29-34.
    >> Share

  111. SANTOS-PARDO I, Lagerqvist B, Ritsinger V, Witt N, et al
    Risk of stent failure in patients with diabetes treated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors: A nationwide observational study.
    Int J Cardiol. 2021;330:23-29.
    >> Share

  112. SENGUTTUVAN NB, Suman F, Paneerselvam T, Malepati B, et al
    Comparison of the effect of Morphine and Fentanyl in patients with acute coronary syndrome receiving Ticagrelor - The COMET (Comparison Morphine, Fentayl and Ticagrelor) randomized controlled trial.
    Int J Cardiol. 2021;330:1-6.
    >> Share

  113. ASLANGER EK, Meyers HP, Bracey A, Smith SW, et al
    The STEMI/NonSTEMI Dichotomy needs to be replaced by Occlusion MI vs. Non-Occlusion MI.
    Int J Cardiol. 2021;330:15.
    >> Share

  114. DEMIR OM, Schrieken C, Curio J, Rahman H, et al
    Behavioural determinants impacting the adoption rate of coronary physiology.
    Int J Cardiol. 2021;330:12-14.
    >> Share

  115. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
    A plasma lipid signature predicts incident coronary artery disease.
    Int J Cardiol. 2021;331:249-254.
    >> Share

  116. SCHERRENBERG M, Janssen J, Lauwers A, Schreurs I, et al
    Is there an optimal dose of cardiac rehabilitation in coronary artery disease patients?
    Int J Cardiol. 2021;330:7-11.
    >> Share

  117. SAMUEL TJ, Wei J, Sharif B, Tamarappoo BK, et al
    Diastolic dysfunction in women with ischemia and no obstructive coronary artery disease: Mechanistic insight from magnetic resonance imaging.
    Int J Cardiol. 2021;331:1-7.
    >> Share

  118. FUNAYAMA N, Kayanuma K, Sunaga D, Yamamoto T, et al
    Serial assessment of de novo coronary lesions after drug-coated balloon treatment analyzed by intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
    Int J Cardiol. 2021;330:35-40.
    >> Share

  119. DI SERAFINO L, Mangiacapra F, Pyxaras S, Morisco C, et al
    Relationship between peripheral arterial reactive hyperemia and the index of myocardial resistance in patients undergoing invasive coronary angiography.
    Int J Cardiol. 2021;333:8-13.
    >> Share

  120. ALMENDRO-DELIA M, Izquierdo-Bajo A, Madrona-Jimenez L, Blanco-Ponce E, et al
    Fondaparinux versus enoxaparin in the contemporary management of non-ST-elevation acute coronary syndromes. Insights from a multicenter registry.
    Int J Cardiol. 2021;332:29-34.
    >> Share

  121. AKSIT E, Altay S, Altun A
    The importance of evaluating coronary sinus blood flow during the coronary sinus reducer treatment.
    Int J Cardiol. 2021;332:38.
    >> Share

  122. SCIAGRA R, Di Paolantonio M, Rubino F, Arnone A, et al
    The STREAM trial: Great expectations for getting clearness in an opaque disease.
    Int J Cardiol. 2021;332:140-141.
    >> Share

  123. CHAO CJ, Shanbhag A, Chiang CC, Girardo ME, et al
    Baseline thrombocytopenia in acute coronary syndrome: The lower, the worse.
    Int J Cardiol. 2021;332:1-7.
    >> Share

  124. XIE Z, Zhu J, Li W, Liu L, et al
    Relationship of epicardial fat volume with coronary plaque characteristics, coronary artery calcification score, coronary stenosis, and CT-FFR for lesion-specific ischemia in patients with known or suspected coronary artery disease.
    Int J Cardiol. 2021;332:8-14.
    >> Share

  125. COMELLA A, Michail M, Chan J, Cameron JD, et al
    Patients with aortic stenosis exhibit early improved endothelial function following transcatheter aortic valve replacement: The eFAST study.
    Int J Cardiol. 2021 Mar 26. pii: S0167-5273(21)00566.
    >> Share

  126. SHYU KG, Wang BW, Lin CM
    Reply to the letter to the Editor "ECs-derived exosomes: A novel therapeutic target for myocardial ischemia-reperfusion injury".
    Int J Cardiol. 2021;332:39.
    >> Share

  127. TIAN B, Li T, Wang M
    MicroRNA-19a might be a new potential therapeutic target in the treatment of coronary artery disease.
    Int J Cardiol. 2021;332:164.
    >> Share

  128. KONST RE, Damman P, Pellegrini D, Hartzema-Meijer MJ, et al
    Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm.
    Int J Cardiol. 2021;333:14-20.
    >> Share

  129. POLZIN A, Helten C, Dannenberg L, Muller T, et al
    Sphingosine-1-phosphate: A mediator of the ARB-MI paradox?
    Int J Cardiol. 2021;333:40-42.
    >> Share

  130. TESCHE C, Ellis L, Brandt V
    Non-invasive plaque morphology-based FFR assessment: A new approach to predict ischemic coronary artery disease?
    Int J Cardiol. 2021;332:223-224.
    >> Share

  131. ALMUKDAD S, Elewa H, Arafa S, Al-Badriyeh D, et al
    Short- and long-term cost-effectiveness analysis of CYP2C19 genotype-guided therapy, universal clopidogrel, versus universal ticagrelor in post-percutaneous coronary intervention patients in Qatar.
    Int J Cardiol. 2021;331:27-34.
    >> Share

  132. SEITZ A, Ong P
    Coexisting microvascular dysfunction in patients with diffuse epicardial coronary spasm: A novel piece of the coronary vasomotor disorder puzzle.
    Int J Cardiol. 2021;331:12-13.
    >> Share

  133. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    >> Share

  134. SAMBOLA A, Soriano-Colome T
    A sex paradox in clinical outcomes following complex percutaneous intervention. Treatment bias, biology or both?
    Int J Cardiol. 2021;329:77-78.
    >> Share

  135. MOHAMED MO, Rashid M, Timmis A, Clarke S, et al
    Sex differences in distribution, management and outcomes of combined ischemic-bleeding risk following acute coronary syndrome.
    Int J Cardiol. 2021;329:16-22.
    >> Share

  136. MARTINSSON A, Nielsen SJ, Bjorklund E, Pivodic A, et al
    Renin-angiotensin system inhibition and outcome after coronary artery bypass grafting: A population-based study from the SWEDEHEART registry.
    Int J Cardiol. 2021;331:40-45.
    >> Share

  137. LEE J, Park DW
    Revascularization or medical therapy for stable coronary artery disease: To do or not to do, that is the question.
    Int J Cardiol. 2021;329:46-47.
    >> Share

  138. CAI Q, Gao ML, Huang LS, Chen HS, et al
    MALAT1/miRNA-203/Wnt5a: A potential mechanism for regulating coronary artery disease.
    Int J Cardiol. 2021;329:48.
    >> Share

  139. HUANG S, Zeng Z, Sun Y, Cai Y, et al
    Association study of hsa_circ_0001946, hsa-miR-7-5p and PARP1 in coronary atherosclerotic heart disease.
    Int J Cardiol. 2021;328:1-7.
    >> Share

  140. REINHOLD J, Papadopoulou C, Baral R, Vassiliou VS, et al
    Iron deficiency for prognosis in acute coronary syndrome - A systematic review and meta-analysis.
    Int J Cardiol. 2021;328:46-54.
    >> Share

  141. YOUSIF N, Niederseer D, Davies A, El Issa M, et al
    Impact of malignancy on clinical outcomes in patients with acute coronary syndromes.
    Int J Cardiol. 2021;328:8-13.
    >> Share

  142. AHMAD A, Corban MT, Lerman A
    Contrast fractional flow reserve vs adenosine fractional flow reserve: The impact of discordant results.
    Int J Cardiol. 2021;328:59-60.
    >> Share

  143. ORBAN M, Ulrich S, Dischl D, von Samson-Himmelstjerna P, et al
    Cardiac allograft vasculopathy: Differences of absolute and relative intimal hyperplasia in children versus adults in optical coherence tomography.
    Int J Cardiol. 2021;328:227-234.
    >> Share

  144. PENG Y
    Reply to renal insufficiency and outcomes in patients with acute coronary syndrome.
    Int J Cardiol. 2021;329:49.
    >> Share

  145. DEKKER M, Waissi F, Bank IEM, Isgum I, et al
    The prognostic value of automated coronary calcium derived by a deep learning approach on non-ECG gated CT images from (82)Rb-PET/CT myocardial perfusion imaging.
    Int J Cardiol. 2021;329:9-15.
    >> Share

  146. HOCHHOLZER W, Valina CM
    Antiplatelet therapy for STEMI: Hit it hard and early?
    Int J Cardiol. 2021;328:61-62.
    >> Share

  147. SCHULZ S, Reichert S, Grollmitz J, Friebe L, et al
    The role of Saccharibacteria (TM7) in the subginival microbiome as a predictor for secondary cardiovascular events.
    Int J Cardiol. 2021;331:255-261.
    >> Share

  148. FABRIS E, Bhatt DL
    Variation in treatment strategy for NSTEMI: A complex phenomenon.
    Int J Cardiol. 2021;331:14-16.
    >> Share

  149. VARGA-SZEMES A, Schoepf UJ, Maurovich-Horvat P, Wang R, et al
    Coronary plaque assessment of Vasodilative capacity by CT angiography effectively estimates fractional flow reserve.
    Int J Cardiol. 2021;331:307-315.
    >> Share

  150. HAITJEMA S, Hoefer IE
    Towards affordable diagnostics and risk management in cardiology: As simple as counting cells?
    Int J Cardiol. 2021;331:206-207.
    >> Share

  151. ECCLESTON D
    Anti-thrombotic therapy for medically managed patients after non-ST segment elevation acute coronary syndromes: Balancing the scales of ischaemic and bleeding risk.
    Int J Cardiol. 2021;331:10-11.
    >> Share

  152. VERDOIA M, De Luca G
    Comments on "Sex differences in distribution, management and outcomes of combined ischemic bleeding risk following acute coronary syndrome".
    Int J Cardiol. 2021;331:8-9.
    >> Share

  153. XIE H, Mao Y, Wang M
    Tackling PTEN induced putative kinase 1 in angiotensin II-induced myocardial injury.
    Int J Cardiol. 2021;331:211.
    >> Share

  154. REINDL M, Reinstadler SJ
    E-wave propagation index (EPI) - A promising echocardiographic marker to improve left ventricular thrombus detection after STEMI?
    Int J Cardiol. 2021;331:331-332.
    >> Share

  155. BETTINK S, Lochel M, Peters D, Haider W, et al
    Efficacy and safety of a magnesium stearate paclitaxel coated balloon catheter in the porcine coronary model.
    Int J Cardiol. 2021;331:46-56.
    >> Share

  156. PARCO C, Brockmeyer M, Kosejian L, Quade J, et al
    Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort.
    Int J Cardiol. 2021;329:28-35.
    >> Share


    J Am Coll Cardiol

  157. HUFFMAN MD, Kwan GF
    RESPONSE: Multilateral Cardiovascular Education and Training in Haiti.
    J Am Coll Cardiol. 2021;77:2752-2753.
    >> Share

  158. RAO VU, Reeves DJ, Chugh AR, O'Quinn R, et al
    Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2021;77:2693-2716.
    >> Share

  159. HAYNES N, Saint-Joy V, Swain J
    Global Health Imperative to Prioritizing Cardiovascular Education.
    J Am Coll Cardiol. 2021;77:2749-2753.
    >> Share

  160. HENRY TD, Garcia S
    Resilience in the Face of Adversity: The Cardiology Community Comes Together.
    J Am Coll Cardiol. 2021;77:2477-2479.
    >> Share


    J Cardiovasc Pharmacol

  161. YUAN JL, Yin CY, Li YZ, Song S, et al
    EZH2 as an epigenetic regulator of cardiovascular development and diseases.
    J Cardiovasc Pharmacol. 2021 May 19. pii: 00005344-900000000-98225.
    >> Share


    J Clin Endocrinol Metab

  162. HOU W, Gao J, Jiang W, Wei W, et al
    Meal Timing of Subtypes of Macronutrients Consumption With Cardiovascular Diseases: NHANES, 2003 to 2016.
    J Clin Endocrinol Metab. 2021 May 26. pii: 6279652. doi: 10.1210.
    >> Share


    J Mol Cell Cardiol

  163. KOVALIK JP, Zhao X, Gao F, Leng S, et al
    Amino acid differences between diabetic older adults and non-diabetic older adults and their associations with cardiovascular function.
    J Mol Cell Cardiol. 2021 May 22. pii: S0022-2828(21)00103.
    >> Share

  164. MOUTON AJ, Flynn ER, Moak SP, Aitken NM, et al
    Dimethyl fumarate preserves left ventricular infarct integrity following myocardial infarction via modulation of cardiac macrophage and fibroblast oxidative metabolism.
    J Mol Cell Cardiol. 2021;158:38-48.
    >> Share


    J Thorac Cardiovasc Surg

  165. TAGGART DP, Gavrilov Y, Krasopoulos G, Rajakaruna C, et al
    External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: A multicenter randomized trial.
    J Thorac Cardiovasc Surg. 2021 Apr 21. pii: S0022-5223(21)00723.
    >> Share

  166. LANUTI M, Lin J, Ng T, Burt BM, et al
    A year in general thoracic surgery published in the Journal of Thoracic and Cardiovascular Surgery: 2020.
    J Thorac Cardiovasc Surg. 2021 Apr 20. pii: S0022-5223(21)00665.
    >> Share

  167. GAUDINO M, Di Franco A, Spadaccio C, Rahouma M, et al
    Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis.
    J Thorac Cardiovasc Surg. 2021 Apr 29. pii: S0022-5223(21)00746.
    >> Share


    N Engl J Med

  168. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    >> Share

  169. LOFFI M, Danzi GB
    Isolated Coronary Artery.
    N Engl J Med. 2021;384:e79.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016